At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Sep 11, 2026 at 19:12 ET
Two insiders at Cytokinetics sold a combined $339K in open-market sales over a week. The EVP of R&D exercised and immediately sold option shares, a classic tax-covering pattern, while a director made a small sale. At a $10.2B market cap, these sales represent ~0.003% of market cap, trivial and routine, not indicative of bearish conviction.
- EVP R&D Malik Fady Ibraham exercised 3,500 options at $7.80/share and immediately sold 3,500 shares at $75.46 for $264K, a routine exercise-and-sell pattern to cover tax obligations.
- Director Robert E. Landry sold 1,000 shares at $74.66 for $75K, a very small position reduction.
- Total open-market sales of $339K represent ~0.003% of CYTK's $10.2B market cap, far below the 0.1% materiality threshold.
- No open-market purchases were made by any insider in this cluster.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access